SOFTGEL CAPSULE
MANUFACTURER INDIA
FOR MYANMAR
WHO-GMP certified softgel capsules from Haryana, India — supplying Myanmar's $161M pharmaceutical import market. Flexible MOQ, competitive pricing, sea and land shipping routes.
Myanmar represents one of the most significant pharmaceutical import markets in Southeast Asia for Indian manufacturers. With pharmaceutical imports from India valued at approximately $161 million in 2024, India holds the position of Myanmar's number one pharmaceutical import source — ahead of Thailand, Indonesia, Singapore, and China. This dominant trade relationship is the product of geographic proximity, competitive Indian manufacturing economics, and decades of established procurement relationships between Indian exporters and Myanmar distributors.
Myanmar's pharmaceutical market serves a population of 54 million with expanding healthcare infrastructure. The country's major generic pharmaceutical companies — including Ranbaxy, Wockhardt, and Cipla — have long-established operations in Myanmar, creating a familiar and trusted trade corridor for Indian pharma products. Myanmar's pharmacy shelves in Yangon, Mandalay, Naypyidaw, and regional cities are stocked predominantly with Indian-manufactured generics and supplements.
Admetus Lifesciences, based in Village Anta, Safidon, Jind, Haryana 126112, manufactures WHO-GMP certified softgel capsules positioned for Myanmar's growing nutraceutical segment. Our product range — from Vitamin D3 and Omega-3 to Glutathione and Ginseng formulations — targets the specific therapeutic categories driving demand in Myanmar's pharmacy retail and healthcare distribution networks.
A significant regulatory development has further opened the market: Myanmar's Companies Act now allows 100% foreign-owned companies to distribute pharmaceutical products domestically. This eliminates the historical requirement for local joint venture partners and enables Indian manufacturers and their distribution partners to establish deeper, more controlled market access. Combined with Myanmar FDA's acceptance of WHO-GMP certification, this creates a streamlined pathway for Indian softgel manufacturers to enter and scale in the Myanmar market.
WHY EXPORT SOFTGELS TO MYANMAR
$161M in pharmaceutical imports from India
Myanmar imported approximately $161 million worth of pharmaceutical products from India in 2024 — making India the single largest source country for Myanmar's pharmaceutical imports. This dominant trade relationship is built on decades of cross-border commerce, geographic proximity, and the established reputation of Indian generic manufacturers. Myanmar's healthcare system relies on Indian generics as the backbone of its pharmaceutical supply chain, and softgel capsules from WHO-GMP certified Indian manufacturers fit directly into this proven procurement corridor.
India is Myanmar's #1 pharmaceutical import source
Among Myanmar's pharmaceutical import partners, India leads ahead of Thailand, Indonesia, Singapore, and China. Indian generics dominate Myanmar's pharmacy shelves — from antibiotics and cardiovascular drugs to vitamins and nutritional supplements. This established market position means Indian manufacturers face less resistance from distributors, pharmacists, and regulators compared to suppliers from other countries. Admetus Lifesciences builds on this established trust with WHO-GMP certified softgel capsules manufactured in Haryana.
100% foreign ownership allowed in pharma distribution
Myanmar's Companies Act now permits 100% foreign-owned companies to distribute pharmaceutical products domestically. This regulatory change has opened the market to Indian pharma companies seeking direct distribution presence — eliminating the traditional requirement for a local joint venture partner. For Admetus Lifesciences and our distribution partners, this means the ability to establish deeper, more controlled market access without ownership restrictions.
Growing healthcare infrastructure and nutraceutical demand
Myanmar's 54 million population has expanding healthcare coverage, a growing urban middle class, and increasing awareness of preventive health and nutritional supplementation. The nutraceutical segment is growing rapidly — driven by urbanization, rising disposable incomes in cities like Yangon and Mandalay, and exposure to health-and-wellness trends from neighboring Thailand and Singapore. Softgel capsules (vitamins, Omega-3, skin health products) are among the fastest-growing categories in Myanmar's pharmacy retail sector.
MYANMAR FDA & IMPORT REGISTRATION
Myanmar's Department of Food and Drug Administration (Myanmar FDA) oversees pharmaceutical import registration. The registration process requires submission of product documentation including Certificate of Analysis, WHO-GMP certificate, Free Sale Certificate, stability data, and product specifications. While this is a formal regulatory process, it is significantly more streamlined than equivalent systems in ASEAN markets like Thailand (Thai FDA) or Singapore (HSA).
The critical credential for Myanmar FDA acceptance is WHO-GMP certificationfrom the manufacturing facility. Admetus Lifesciences holds WHO-GMP certification for our Jind, Haryana facility — the same standard accepted by Myanmar FDA and recognized as the baseline quality benchmark for imported pharmaceutical products. This certification is what allows Indian generics to dominate Myanmar's pharmaceutical market.
India's major generic pharmaceutical companies — Ranbaxy, Wockhardt, Cipla, Dr. Reddy's, and others — already operate in Myanmar with registered products. This established trade corridor means that Myanmar FDA reviewers are familiar with Indian manufacturing documentation formats, WHO-GMP certificates issued by Indian state drug controllers, and the general quality profile of Indian pharmaceutical products. New Indian manufacturers entering the Myanmar market benefit from this established familiarity.
Admetus Lifesciences provides all manufacturer-side documentation required for Myanmar FDA registration: WHO-GMP certificate, GMP certificate, Free Sale Certificate from FSSAI, Certificate of Analysis per batch, product master file, stability data, manufacturing process documentation, and Certificate of Origin. The buyer or their Myanmar-based regulatory agent handles the in-country registration submission.
SOFTGEL FORMULATIONS FOR MYANMAR
Cholecalciferol (Vitamin D3) 60,000 IU
Vitamin D deficiency is common across Southeast Asia, including Myanmar — driven by indoor lifestyles in urban areas and dietary gaps. Cholecalciferol 60,000 IU softgels serve as weekly therapeutic supplementation prescribed across Myanmar's clinics and pharmacies. The product is procured both through established pharmacy chains in Yangon and Mandalay, and through rural health programs addressing widespread nutritional deficiencies.
Omega-3 Fatty Acids + Vitamin E
Cardiovascular health awareness is growing rapidly among Myanmar's urban population. Omega-3 softgels with Vitamin E support cardiac health, triglyceride management, and anti-inflammatory response — a high-demand category in Myanmar's expanding pharmacy retail sector. The product competes effectively against Thai and Singaporean imports on both price and quality certification.
Multivitamin Softgel Capsules
Broad-spectrum nutritional supplementation addressing micronutrient deficiencies across Myanmar's population. Multivitamin softgels are a staple in Myanmar's pharmacy distribution networks — from urban chains in Yangon to regional distributors serving smaller cities and rural areas. Our formulation covers essential vitamins and minerals in a single daily softgel dose.
Ginseng + Astaxanthin (Energy & Vitality)
Energy and vitality supplements are extremely popular across Southeast Asian markets, and Myanmar is no exception. Ginseng combined with Astaxanthin (a powerful antioxidant from microalgae) addresses the growing demand for performance, energy, and anti-fatigue products — particularly among Myanmar's urban working population. This formulation category is one of the fastest-growing segments in SE Asian nutraceutical markets.
Krill Oil Softgel Capsules
Krill oil delivers Omega-3 fatty acids in phospholipid form for superior bioavailability compared to standard fish oil. The product targets Myanmar's premium supplement segment — health-conscious consumers in Yangon and Mandalay willing to pay for advanced formulations. Krill oil softgels are positioned as a premium alternative to standard Omega-3, with strong demand from Myanmar's growing wellness retail channel.
Glutathione Softgel Capsules (Skin Health)
Glutathione is the single most demanded skin health supplement across Southeast Asia — driven by strong consumer preference for skin brightening and antioxidant protection. In Myanmar, as in Thailand, the Philippines, and Indonesia, glutathione supplements command premium pricing and sustained consumer loyalty. Our softgel encapsulation delivers standardized glutathione with enhanced absorption, meeting the specific product expectations of the SE Asian market.
Beyond these core formulations, Admetus Lifesciences develops custom softgel blends for Myanmar distributors targeting specific therapeutic or wellness categories. Southeast Asian market formulation trends (skin health, energy, detox) are well-understood and supported. Custom formulation requests are evaluated within 48 hours. Contact us at [email protected] with your formulation requirements.
INDIA TO MYANMAR SHIPPING ROUTES
Two distinct shipping routes connect our Haryana facility to Myanmar — sea freight to Thilawa port (Yangon) or overland via the Moreh-Tamu border crossing. Transit time: 7-12 days (sea) or 5-8 days (land).
- 01
Production & QC at Jind facility
Softgel capsules manufactured on the ARBES SGX-806P line, dried under controlled conditions, and subjected to multi-point quality testing — visual inspection, weight uniformity, dissolution, microbial limits. Full Certificate of Analysis (COA) generated per batch.
- 02
Export packaging & documentation
Products packed in export-grade secondary packaging with desiccants and tamper-evident sealing. Export documentation prepared: COA, WHO-GMP certificate, Free Sale Certificate (FSSAI), commercial invoice, packing list, bill of lading, and Myanmar FDA registration documents where applicable.
- 03
Dispatch from Chennai, Kolkata, or JNPT port
Sea freight from Chennai (closest major port for Bay of Bengal route), Kolkata (India's primary east-coast port), or JNPT (Nhava Sheva, Mumbai) — all offering regular container services to Yangon. Chennai and Kolkata provide the shortest transit times due to geographic proximity.
- 04
Arrival at Thilawa port (Yangon)
Direct sea route to Thilawa International Terminal, Myanmar's modern deep-water port facility located 25 km south of Yangon. Thilawa is Myanmar's primary container port and includes a Special Economic Zone (SEZ) that supports pharmaceutical import and distribution operations.
- 05
Alternative: India-Myanmar land route
Land transport is also possible via India's Northeast — the Moreh-Tamu border crossing connects India's Manipur state to Myanmar's Sagaing Region. This route is used for smaller consignments and offers an alternative when sea freight timelines or costs are less favorable. The India-Myanmar-Thailand Trilateral Highway is improving overland connectivity.
- 06
Transit time: 7-12 days (sea) / 5-8 days (land)
Sea freight from Chennai/Kolkata to Thilawa (Yangon) takes approximately 7-12 days depending on the shipping line and route. The Moreh-Tamu land route can deliver in 5-8 days for smaller consignments. Air freight via Delhi or Kolkata to Yangon International Airport is available for urgent or sample shipments with 2-3 day delivery.
WHY MYANMAR DISTRIBUTORS CHOOSE ADMETUS
WHO-GMP certified — Myanmar FDA accepted. The single most important credential for pharmaceutical imports into Myanmar. Our WHO-GMP certification from the Jind, Haryana facility is the same standard accepted by Myanmar FDA and recognized across ASEAN pharmaceutical markets. This certification enables product registration and import clearance without additional facility audits.
Competitive pricing vs Thai and Chinese suppliers. Myanmar's pharmaceutical market is price-sensitive, and Indian manufacturers compete primarily against Thai and Chinese suppliers. Our Haryana manufacturing economics deliver WHO-GMP certified softgels at pricing that is competitive with Chinese manufacturers while offering the quality documentation and regulatory acceptance that Thai products carry — the best of both positioning.
Flexible MOQ for fragmented distributor market. Myanmar's pharmaceutical distribution is highly fragmented — hundreds of small-to-medium distributors operate across different regions, cities, and ethnic states. Not every distributor can commit to full-container loads. Admetus supports pilot shipments for new distributors as well as scaled orders for established importers, accommodating Myanmar's market structure.
Full export documentation for Myanmar FDA.We provide all manufacturer-side documentation required for Myanmar FDA registration and import clearance — WHO-GMP certificate, COA, Free Sale Certificate, stability data, product master file, and Certificate of Origin. Our documentation package is formatted for Myanmar FDA submission requirements, reducing the administrative burden on the importer's regulatory team.
MYANMAR EXPORT Q&A
01What is the Myanmar FDA registration process for imported softgel capsules?
Myanmar's Department of Food and Drug Administration (FDA) requires registration for pharmaceutical imports. The process involves submitting product documentation including Certificate of Analysis, WHO-GMP certificate, Free Sale Certificate, and product specifications. WHO-GMP certification from the manufacturer is accepted as the primary quality credential. India's established pharmaceutical trade relationship with Myanmar — with major Indian companies like Ranbaxy, Wockhardt, and Cipla already operating in the market — means the registration pathway for Indian manufacturers is well-documented and familiar to Myanmar FDA reviewers. Admetus provides all manufacturer-side documentation required for registration.
02What documentation does Admetus provide for Myanmar imports?
We provide comprehensive export documentation: Certificate of Analysis (COA) per batch, WHO-GMP certificate, GMP certificate, Free Sale Certificate from FSSAI, Certificate of Origin, commercial invoice with HS codes, packing list, and bill of lading. For Myanmar FDA registration, we also provide product master files, stability data, and manufacturing process documentation as required. All documents are prepared in English, which is the standard language for pharmaceutical documentation in Myanmar.
03What is the minimum order quantity for export to Myanmar?
MOQs are flexible and designed to accommodate Myanmar's fragmented distributor market. Myanmar's pharmaceutical distribution is characterized by many small-to-medium distributors operating across different regions — not every importer can commit to full-container loads. We support pilot shipments for new Myanmar distributors establishing product lines, as well as bulk orders for established importers. Specific MOQ for your order is confirmed within 48 hours of inquiry at [email protected].
04What are the shipping routes from India to Myanmar?
Two primary routes: (1) Sea freight from Chennai or Kolkata to Thilawa port (Yangon) — approximately 7-12 days transit via the Bay of Bengal and Andaman Sea. JNPT (Mumbai) is also available but with longer transit time. (2) Land route via Moreh (Manipur, India) to Tamu (Sagaing, Myanmar) — approximately 5-8 days for smaller consignments. The sea route is standard for full-container loads; the land route offers flexibility for smaller or urgent shipments. Air freight via Kolkata or Delhi to Yangon is available for samples (2-3 days).
05Which softgel products have the highest demand in Myanmar?
The highest-demand categories in Myanmar are: (1) Glutathione — skin health is the single largest nutraceutical category in Southeast Asia, and Myanmar follows this trend strongly. (2) Multivitamins — broad-spectrum nutritional supplementation for a market with significant micronutrient gaps. (3) Omega-3 / Krill Oil — cardiovascular health awareness is growing among urban consumers. (4) Vitamin D3 — deficiency correction is increasingly recognized by Myanmar's healthcare practitioners. (5) Ginseng + Astaxanthin — energy and vitality products are popular across SE Asian markets. We can customize formulations based on specific market positioning and distributor requirements.
06Can you manufacture private-label softgels for the Myanmar market?
Yes. We operate as a private-label and contract manufacturer — your brand name, packaging design, and labeling specifications are applied to the finished product. We support Myanmar-language (Burmese) labeling as required by Myanmar FDA for consumer-facing products. Brand artwork approval and proof signoff happens before production begins. Private labeling is particularly relevant in Myanmar's market where local brand identity drives consumer preference. See our private label softgel manufacturer page for the full process.
EXPORT SOFTGELS TO MYANMAR
For Myanmar importers and distributors seeking a WHO-GMP certified softgel capsule manufacturer in India — share your requirements and our export team will respond within 48 hours.